Mice lacking collapsin response mediator protein 1 manifest hyperactivity, impaired learning and memory, and impaired prepulse inhibition

Collapsin response mediator protein 1 (CRMP1) is one of the CRMP family members that are involved in various aspects of neuronal development such as axonal guidance and neuronal migration. Here we provide evidence that crmp1−/− mice exhibited behavioral abnormalities related to schizophrenia. The crmp1−/− mice exhibited hyperactivity and/or impaired emotional behavioral phenotype. These mice also exhibited impaired context-dependent memory and long-term memory retention. Furthermore, crmp1−/− mice exhibited decreased prepulse inhibition, and this phenotype was rescued by administration of chlorpromazine, a typical antipsychotic drug. In addition, in vivo microdialysis revealed that the methamphetamine-induced release of dopamine in prefrontal cortex was exaggerated in crmp1−/− mice, suggesting that enhanced mesocortical dopaminergic transmission contributes to their hyperactivity phenotype. These observations suggest that impairment of CRMP1 function may be involved in the pathogenesis of schizophrenia. We propose that crmp1−/− mouse may model endophenotypes present in this neuropsychiatric disorder.

[1]  G. Salmon,et al.  Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.

[2]  Y. Goshima,et al.  Phosphorylation of CRMP2 is involved in proper bifurcation of the apical dendrite of hippocampal CA1 pyramidal neurons , 2013, Developmental neurobiology.

[3]  T. Abe,et al.  CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus , 2012, Developmental neurobiology.

[4]  W. Hennah,et al.  Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits. , 2012, Human molecular genetics.

[5]  Y. Goshima,et al.  Collapsin Response Mediator Proteins Regulate Neuronal Development and Plasticity by Switching Their Phosphorylation Status , 2012, Molecular Neurobiology.

[6]  K. Mikoshiba,et al.  Phosphorylation of CRMP2 (Collapsin Response Mediator Protein 2) Is Involved in Proper Dendritic Field Organization , 2012, The Journal of Neuroscience.

[7]  S. Carr,et al.  Cdk5 Is Required for Memory Function and Hippocampal Plasticity via the cAMP Signaling Pathway , 2011, PloS one.

[8]  T. Hortobágyi,et al.  Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. , 2011, Brain : a journal of neurology.

[9]  Taisuke Kawasaki,et al.  Serotonin Mediates Cross-Modal Reorganization of Cortical Circuits , 2011, Neuron.

[10]  Y. Goshima,et al.  CRMP5 (Collapsin Response Mediator Protein 5) Regulates Dendritic Development and Synaptic Plasticity in the Cerebellar Purkinje Cells , 2011, The Journal of Neuroscience.

[11]  Takuya Takahashi,et al.  Serotonin mediates cross-modal reorganization of cortical circuits , 2010, Neuroscience Research.

[12]  Andreas Meyer-Lindenberg,et al.  The neurobiology of schizophrenia: new leads and avenues for treatment , 2010, Current Opinion in Neurobiology.

[13]  L. Garey When cortical development goes wrong: schizophrenia as a neurodevelopmental disease of microcircuits , 2010, Journal of anatomy.

[14]  T. Miyakawa,et al.  Elevated Plus Maze for Mice , 2008, Journal of visualized experiments : JoVE.

[15]  K. Nakayama,et al.  Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants. , 2008, Human molecular genetics.

[16]  K. Fukunaga,et al.  Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders , 2008, European Psychiatry.

[17]  M. Baudry,et al.  The FASEB Journal • Research Communication CRMP3 is required for hippocampal CA1 dendritic organization and plasticity , 2022 .

[18]  P. Fletcher,et al.  The amphetamine-induced sensitized state as a model of schizophrenia , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[19]  J. Honnorat,et al.  Regulation of Spine Development by Semaphorin3A through Cyclin-Dependent Kinase 5 Phosphorylation of Collapsin Response Mediator Protein 1 , 2007, The Journal of Neuroscience.

[20]  J. Shih,et al.  Mice Deficient in Collapsin Response Mediator Protein-1 Exhibit Impaired Long-Term Potentiation and Impaired Spatial Learning and Memory , 2007, The Journal of Neuroscience.

[21]  K. Mikoshiba,et al.  Collapsin Response Mediator Protein 1 Mediates Reelin Signaling in Cortical Neuronal Migration , 2006, The Journal of Neuroscience.

[22]  Paul Antoine Salin,et al.  Transient alterations in granule cell proliferation, apoptosis and migration in postnatal developing cerebellum of CRMP1−/– mice , 2006, Genes to cells : devoted to molecular & cellular mechanisms.

[23]  T. Miyakawa,et al.  Investigating Gene‐to‐Behavior Pathways in Psychiatric Disorders , 2006, Annals of the New York Academy of Sciences.

[24]  G D Pearlson,et al.  Neurobiology of schizophrenia , 2000, Annals of neurology.

[25]  B. Eickholt,et al.  Distinct Priming Kinases Contribute to Differential Regulation of Collapsin Response Mediator Proteins by Glycogen Synthase Kinase-3 in Vivo* , 2006, Journal of Biological Chemistry.

[26]  Kyla Pennington,et al.  Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes , 2006, Proteomics.

[27]  S. Hirsch,et al.  Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics , 2006, Experimental Brain Research.

[28]  Jie Qin,et al.  Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice , 2005, Nature Neuroscience.

[29]  R. Buchanan,et al.  Dihydropyrimidinase‐related protein 2 (DRP‐2) gene and association to deficit and nondeficit schizophrenia , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  David A Lewis,et al.  Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. , 2005, The American journal of psychiatry.

[31]  R. Rodriguiz,et al.  Neural Cell Adhesion Molecule-secreting Transgenic Mice Display Abnormalities in Gabaergic Interneurons and Alterations in Behavior , 2022 .

[32]  S. Fatemi,et al.  Reelin glycoprotein: structure, biology and roles in health and disease , 2005, Molecular Psychiatry.

[33]  K. Mikoshiba,et al.  Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[34]  K. Kaibuchi,et al.  GSK-3β Regulates Phosphorylation of CRMP-2 and Neuronal Polarity , 2005, Cell.

[35]  L. Tsai,et al.  Cyclin-Dependent Kinase 5 Phosphorylates the N-Terminal Domain of the Postsynaptic Density Protein PSD-95 in Neurons , 2004, The Journal of Neuroscience.

[36]  M. Noda,et al.  Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization , 2003, The European journal of neuroscience.

[37]  K. Kaibuchi,et al.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly , 2002, Nature Cell Biology.

[38]  J. Radulovic,et al.  Cyclin-Dependent Kinase 5 Is Required for Associative Learning , 2002, The Journal of Neuroscience.

[39]  R. Gainetdinov,et al.  Genetic animal models: focus on schizophrenia , 2001, Trends in Neurosciences.

[40]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[41]  M. Noda,et al.  Molecular Characterization of CRMP5, a Novel Member of the Collapsin Response Mediator Protein Family* , 2000, The Journal of Biological Chemistry.

[42]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[43]  S. Yanagi,et al.  Identification of CRAM, a novel unc-33 gene family protein that associates with CRMP3 and protein-tyrosine kinase(s) in the developing rat brain. , 2000, The Journal of biological chemistry.

[44]  J. Swanson,et al.  Attention deficit/hyperactivity disorder: characteristics, interventions and models. , 2000, Neurotoxicology and teratology.

[45]  P. Greengard,et al.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons , 1999, Nature.

[46]  M. Laruelle,et al.  Increased dopamine transmission in schizophrenia: relationship to illness phases , 1999, Biological Psychiatry.

[47]  Yogesh K. Dwivedi,et al.  The phenotypic characteristics of heterozygous reeler mouse. , 1999, Neuroreport.

[48]  Yogesh K. Dwivedi,et al.  A decrease of reelin expression as a putative vulnerability factor in schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Crawley,et al.  Inbred strain differences in prepulse inhibition of the mouse startle response , 1997, Psychopharmacology.

[50]  A. Malhotra,et al.  Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Strittmatter,et al.  A Family of Rat CRMP Genes Is Differentially Expressed in the Nervous System , 1996, The Journal of Neuroscience.

[52]  A. Sobel,et al.  Identification and molecular characterization of Unc-33-like phosphoprotein (Ulip), a putative mammalian homolog of the axonal guidance-associated unc-33 gene product , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[53]  S. Hockfield,et al.  TOAD-64, a gene expressed early in neuronal differentiation in the rat, is related to unc-33, a C. elegans gene involved in axon outgrowth , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[54]  Fumio Nakamura,et al.  Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33 , 1995, Nature.

[55]  Joseph E LeDoux,et al.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.

[56]  D L Braff,et al.  Sensorimotor gating and schizophrenia. Human and animal model studies. , 1990, Archives of general psychiatry.

[57]  廣島 幸彦 膵癌の浸潤、転移過程におけるCollapsin Response Mediator Protein4の役割 , 2013 .

[58]  吉村 武 GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity , 2005 .

[59]  J. Lieberman,et al.  Provocative tests with psychostimulant drugs in schizophrenia , 2004, Psychopharmacology.

[60]  Greg D. Gale,et al.  Hippocampus and contextual fear conditioning: Recent controversies and advances , 2001, Hippocampus.

[61]  R. Yolken,et al.  Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder , 2000, Molecular Psychiatry.

[62]  Joseph E LeDoux,et al.  Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus , 2000, Nature Neuroscience.

[63]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[64]  R. Faull,et al.  Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia , 2000, Molecular Psychiatry.

[65]  M. Nonaka,et al.  A novel gene family defined by human dihydropyrimidinase and three related proteins with differential tissue distribution. , 1996, Gene.